Ontology highlight
ABSTRACT:
SUBMITTER: Shih TC
PROVIDER: S-EPMC7771890 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
Shih Tsung-Chieh TC Wang Lijun L Wang Hsiao-Chi HC Wan Yu-Jui Yvonne YY
Liver research (Beijing, China) 20201111 4
Hepatocellular carcinoma (HCC) is a malignant tumor with a fairly poor prognosis (5-year survival of less than 50%). Using sorafenib, the only food and drug administration (FDA)-approved drug, HCC cannot be effectively treated; it can only be controlled at most for a couple of months. There is a great need to develop efficacious treatment against this debilitating disease. Glypican-3 (GPC3), a member of the glypican family that attaches to the cell surface by a glycosylphosphatidylinositol ancho ...[more]